Percutaneous Radiofrequency Ablation of Small Renal Tumors Using CT-Guidance: A Review and Its Current Role

Urology Journal

Volumn 9, Issue 4, 2012, Pages 629-638

  Haddad, Richard L ^a,b,c,d   Patel, Manish I ^d   Vladica, Philip ^e   Kassouf, Wassim ^a,b   Bladou, Frank ^a,c   Anidjar, Maurice ^a,c  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b MONTREAL GENERAL HOSPITAL   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d ROYAL AUSTRALASIAN COLLEGE OF SURGEONS   (Australia)

^e Westmead Private Hospital   (Australia)

Author keywords

Computed tomography; Percutaneous; Radiofrequency ablation; Renal cell carcinoma

Indexed keywords

CATHETER ABLATION; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; INTERVENTIONAL RADIOLOGY; KIDNEY TUMOR; PATIENT CARE; RADIOGRAPHY; REVIEW;

CATHETER ABLATION; HUMANS; KIDNEY NEOPLASMS; PATIENT CARE TEAM; RADIOLOGY, INTERVENTIONAL; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84876426984     PISSN: 17351308     EISSN: 1735546X     Source Type: Journal    
DOI: None     Document Type: Review

References (60)

1. Chow WH, Devesa SS, Warren JL, Fraumeni JF, Jr. Rising incidence of renal cell cancer in the United States. JAMA. 1999;281:1628-31.
2. Nepple K, Strope S. 961 Population-Based Analysis Of The Rising Incidence Of Renal Cancer: Evaluation Of Age-Specific Trends (1975-2006). J Urol. 2011;185:e387-e.
3. Chawla SN, Crispen PL, Hanlon AL, Greenberg RE, Chen DY, Uzzo RG. The natural history of observed enhancing renal masses: meta-analysis and review of the world literature. J Urol. 2006;175:425-31.
4. Frank I, Blute ML, Cheville JC, Lohse CM, Weaver AL, Zincke H. Solid renal tumors: an analysis of pathological features related to tumor size. J Urol. 2003;170:2217-20.
5. Doeuk N, Guo DY, Haddad R, et al. Renal cell carcinoma: stage, grade and histology migration over the last 15 years in a large Australian surgical series. BJU Int. 2011;107:1381-5.
6. Zlotta AR, Wildschutz T, Raviv G, et al. Radiofrequency interstitial tumor ablation (RITA) is a possible new modality for treatment of renal cancer: ex vivo and in vivo experience. J Endourol. 1997;11:251-8.
7. Moch H, Artibani W, Delahunt B, et al. Reassessing the current UICC/AJCC TNM staging for renal cell carcinoma. Eur Urol. 2009;56:636-43.
8. Lee CT, Katz J, Shi W, Thaler HT, Reuter VE, Russo P. Surgical management of renal tumors 4 cm. or less in a contemporary cohort. J Urol. 2000;163:730-6.
9. Lerner SE, Hawkins CA, Blute ML, et al. Disease outcome in patients with low stage renal cell carcinoma treated with nephron sparing or radical surgery 1996. J Urol. 2002;167:884-9; discussion 9-90.
10. Watkins TW, Parkinson R. Percutaneous radiofrequency ablation of renal tumours: case series of 11 tumours and review of published work. Australas Radiol. 2007;51:412-9.
11. Sabharwal R, Vladica P. Renal tumors: technical success and early clinical experience with radiofrequency ablation of 18 tumors. Cardiovasc Intervent Radiol. 2006;29:202-9.
12. Wah TM, Arellano RS, Gervais DA, et al. Image-guided percutaneous radiofrequency ablation and incidence of post-radiofrequency ablation syndrome: prospective survey. Radiology. 2005;237:1097-102.
13. Gervais DA, Arellano RS, McGovern FJ, McDougal WS, Mueller PR. Radiofrequency ablation of renal cell carcinoma: part 2, Lessons learned with ablation of 100 tumors. AJR Am J Roentgenol. 2005;185:72-80.
14. Farrell MA, Charboneau WJ, DiMarco DS, et al. Imagingguided radiofrequency ablation of solid renal tumors. AJR Am J Roentgenol. 2003;180:1509-13.
15. Mayo-Smith WW, Dupuy DE, Parikh PM, Pezzullo JA, Cronan JJ. Imaging-guided percutaneous radiofrequency ablation of solid renal masses: techniques and outcomes of 38 treatment sessions in 32 consecutive patients. AJR Am J Roentgenol. 2003;180:1503-8.
16. Pavlovich CP, Walther MM, Choyke PL, et al. Percutaneous radio frequency ablation of small renal tumors: initial results. J Urol. 2002;167:10-5.
17. Tracy CR, Raman JD, Donnally C, Trimmer CK, Cadeddu JA. Durable oncologic outcomes after radiofrequency ablation: experience from treating 243 small renal masses over 7.5 years. Cancer. 2010;116:3135-42.
18. Bandi G, Hedican SP, Nakada SY. Current practice patterns in the use of ablation technology for the management of small renal masses at academic centers in the United States. Urology. 2008;71:113-7.
19. Boss A, Clasen S, Kuczyk M, Schick F, Pereira PL. Imageguided radiofrequency ablation of renal cell carcinoma. Eur Radiol. 2007;17:725-33.
20. Sapareto SA, Dewey WC. Thermal dose determination in cancer therapy. Int J Radiat Oncol Biol Phys. 1984;10:787-800.
21. Zelkovic PF, Resnick MI. Renal radiofrequency ablation: clinical status 2003. Curr Opin Urol. 2003;13:199-202.
22. McDougal WS. Radiofrequency ablation of renal cell carcinoma. BJU Int. 2007;99:1271-2.
23. McAchran SE, Lesani OA, Resnick MI. Radiofrequency ablation of renal tumors: past, present, and future. Urology. 2005;66:15-22.
24. Farrell MA, Charboneau JW, Callstrom MR, Reading CC, Engen DE, Blute ML. Paranephric water instillation: a technique to prevent bowel injury during percutaneous renal radiofrequency ablation. AJR Am J Roentgenol. 2003;181:1315-7.
25. Arellano RS, Garcia RG, Gervais DA, Mueller PR. Percutaneous CT-guided radiofrequency ablation of renal cell carcinoma: efficacy of organ displacement by injection of 5% dextrose in water into the retroperitoneum. AJR Am J Roentgenol 2009;193:1686-90.
26. Ginat DT, Saad W, Davies M, Walman D, Erturk E. Bowel displacement for CT-guided tumor radiofrequency ablation: techniques and anatomic considerations. J Endourol. 2009;23:1259-64.
27. Ginat DT, Saad WE. Bowel displacement and protection techniques during percutaneous renal tumor thermal ablation. Tech Vasc Interv Radiol. 2010;13:66-74.
28. Kam AW, Littrup PJ, Walther MM, Hvizda J, Wood BJ. Thermal protection during percutaneous thermal ablation of renal cell carcinoma. J Vasc Interv Radiol. 2004;15:753-8.
29. Wah TM, Koenig P, Irving HC, Gervais DA, Mueller PR. Radiofrequency ablation of a central renal tumor: protection of the collecting system with a retrograde cold dextrose pyeloperfusion technique. J Vasc Interv Radiol. 2005;16:1551-5.
30. Schreyer HH, Uggowitzer MM, Ruppert-Kohlmayr A. Helical CT of the urinary organs. Eur Radiol. 2002;12:575-91.
31. Lewin JS, Nour SG, Connell CF, et al. Phase II clinical trial of interactive MR imaging-guided interstitial radiofrequency thermal ablation of primary kidney tumors: initial experience. Radiology. 2004;232:835-45.
32. Zagoria RJ, Hawkins AD, Clark PE, et al. Percutaneous CTguided radiofrequency ablation of renal neoplasms: factors influencing success. AJR Am J Roentgenol. 2004;183:201-7.
33. Arzola J, Baughman SM, Hernandez J, Bishoff JT. Computed tomography-guided, resistance-based, percutaneous radiofrequency ablation of renal malignancies under conscious sedation at two years of follow-up. Urology. 2006;68:983-7.
34. Matsumoto ED, Johnson DB, Ogan K, et al. Short-term efficacy of temperature-based radiofrequency ablation of small renal tumors. Urology. 2005;65:877-81.
35. Javadi S, Ahrar JU, Ninan E, Gupta S, Matin SF, Ahrar K. Characterization of contrast enhancement in the ablation zone immediately after radiofrequency ablation of renal tumors. J Vasc Interv Radiol. 2010;21:690-5.
36. Davenport MS, Caoili EM, Cohan RH, et al. MRI and CT characteristics of successfully ablated renal masses: Imaging surveillance after radiofrequency ablation. AJR Am J Roentgenol. 2009;192:1571-8.
37. Marcovich R, Aldana JP, Morgenstern N, Jacobson AI, Smith AD, Lee BR. Optimal lesion assessment following acute radio frequency ablation of porcine kidney: cellular viability or histopathology? J Urol. 2003;170:1370-4.
38. Ferakis N, Bouropoulos C, Granitsas T, Mylona S, Poulias I. Long-term results after computed-tomography-guided percutaneous radiofrequency ablation for small renal tumors. J Endourol. 2010;24:1909-13.
39. Hiraoka K, Kawauchi A, Nakamura T, Soh J, Mikami K, Miki T. Radiofrequency ablation for renal tumors: our experience. Int J Urol. 2009;16:869-73.
40. Watanabe F, Kawasaki T, Hotaka Y, et al. Radiofrequency ablation for the treatment of renal cell carcinoma: initial experience. Radiat Med. 2008;26:1-5.
41. Kim JH, Kim TH, Kim SD, Lee KS, Sung GT. Radiofrequency ablation of renal tumors: our experience. Korean J Urol. 2011;52:531-7.
42. Levinson AW, Su LM, Agarwal D, et al. Long-term oncological and overall outcomes of percutaneous radio frequency ablation in high risk surgical patients with a solitary small renal mass. J Urol. 2008;180:499-504; discussion.
43. Raman JD, Stern JM, Zeltser I, Kabbani W, Cadeddu JA. Absence of viable renal carcinoma in biopsies performed more than 1 year following radio frequency ablation confirms reliability of axial imaging. J Urol. 2008;179:2142-5.
44. Nitta Y, Tanaka T, Morimoto K, et al. Intermediate oncological outcomes of percutaneous radiofrequency ablation for small renal tumors: initial experience. Anticancer Res. 2012;32:615-8.
45. Park BK, Kim CK, Lee HM. Image-guided radiofrequency ablation of Bosniak category III or IV cystic renal tumors: initial clinical experience. Eur Radiol. 2008;18:1519-25.
46. Hegarty NJ, Gill IS, Desai MM, Remer EM, O'Malley CM, Kaouk JH. Probe-ablative nephron-sparing surgery: cryoablation versus radiofrequency ablation. Urology. 2006;68:7-13.
47. Park S, Anderson JK, Matsumoto ED, Lotan Y, Josephs S, Cadeddu JA. Radiofrequency ablation of renal tumors: intermediate-term results. J Endourol. 2006;20:569-73.
48. Ahrar K, Matin S, Wood CG, et al. Percutaneous radiofrequency ablation of renal tumors: technique, complications, and outcomes. J Vasc Interv Radiol. 2005;16:679-88.
49. Gervais DA, McGovern FJ, Arellano RS, McDougal WS, Mueller PR. Radiofrequency ablation of renal cell carcinoma: part 1, Indications, results, and role in patient management over a 6-year period and ablation of 100 tumors. AJR Am J Roentgenol. 2005;185:64-71.
50. McGovern FJ, Wood BJ, Goldberg SN, Mueller PR. Radio frequency ablation of renal cell carcinoma via image guided needle electrodes. J Urol. 1999;161:599-600.
51. Rane A, Stein R, Cadeddu J. Focal therapy for renal mass lesions: where do we stand in 2012? BJU Int. 2012;109:491-2.
52. Best SL, Park SK, Yaacoub RF, et al. Long-term outcomes of renal tumor radio frequency ablation stratified by tumor diameter: size matters. J Urol. 2012;187:1183-9.
53. Tan YK, Best SL, Olweny E, Park S, Trimmer C, Cadeddu JA. Radiofrequency ablation of incidental benign small renal mass: outcomes and follow-up protocol. Urology. 2012;79:827-30.
54. Stern JM, Svatek R, Park S, et al. Intermediate comparison of partial nephrectomy and radiofrequency ablation for clinical T1a renal tumours. BJU Int. 2007;100:287-90.
55. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205-13.
56. Varkarakis IM, Allaf ME, Inagaki T, et al. Percutaneous radio frequency ablation of renal masses: results at a 2-year mean followup. J Urol. 2005;174:456-60; discussion 60.
57. Kimura M, Baba S, Polascik TJ. Minimally invasive surgery using ablative modalities for the localized renal mass. Int J Urol. 2010;17:215-27.
58. Igor Pinkhasov G, Raman JD. Management and prevention of renal ablative therapy complications. World J Urol. 2010;28:559-64.
59. Weizer AZ, Raj GV, O'Connell M, Robertson CN, Nelson RC, Polascik TJ. Complications after percutaneous radiofrequency ablation of renal tumors. Urology. 2005;66:1176-80.
60. Park BK, Kim CK, Lim HK. Renal infarction resulting from segmental arterial injury during radiofrequency ablation of renal tumor in patient with a single kidney. Urology. 2009;73:442 e9-11.